| Tanshinone IIA inhibits human breast cancer cells through increased Bax to Bcl-xL ratios. | |
| | |
MedLine Citation:
|
PMID: 18698495 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Tanshinone IIA (C19H18O3) was extracted from danshen (Salviae miltiorrhizae radix). It has cytotoxic properties and induces apoptosis in many human cancer cells. The molecular mechanisms are poorly understood, therefore, in the present study, we aimed to elucidate its anticancer activity on human breast cancer MDA-MB-231 cells. The cytotoxic effects of tanshinone IIA on MDA-MB-231 cells were measured by MTT assay. The percentages of cells in different cell cycle phases were determined by flow cytometry. The protein expression of Bax and Bcl-2 was examined using Western blotting. The results showed that tanshinone IIA inhibits the proliferation of MDA-MB-231 cells in a dose- and time-dependent manner. Tanshinone IIA induces apoptosis in a dose-dependent manner and the percentage of cells in sub-G1 phase. It increases the protein expression of Bax but decreases the Bcl-2 expression in MDA-MB-231 cells. Our findings suggest that tanshinone IIA can inhibit the proliferation of MDA-MB-231 cells by active apoptosis. One of the mechanisms may be through up-regulating the expression of Bax but down-regulating Bcl-2 expression and then inducing apoptosis. In conclusion, tanshinone IIA has therapeutic potential in breast cancer patients. |
| | |
Authors:
|
Chin-Cheng Su; Yi-Hsiang Lin |
Related Documents
:
|
11266525 - Follicular lymphoma with marginal zone differentiation: microdissection demonstrates th... 18293405 - Domoic acid induces direct dna damage and apoptosis in caco-2 cells: recent advances. 7798385 - Melanocytes in human skin express bcl-2 protein. 12485875 - Association of bcl-2 with cyclin a/cdk-2 complex and its effects on cdk-2 activity. 21283595 - Coordinating changes in cell adhesion and phenotype during emt-like processes in cancer. 1506435 - Characterization of the enterocyte-like brush border cytoskeleton of the c2bbe clones o... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: International journal of molecular medicine Volume: 22 ISSN: 1107-3756 ISO Abbreviation: Int. J. Mol. Med. Publication Date: 2008 Sep |
Date Detail:
|
Created Date: 2008-08-13 Completed Date: 2008-10-03 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9810955 Medline TA: Int J Mol Med Country: Greece |
Other Details:
|
Languages: eng Pagination: 357-61 Citation Subset: IM |
Affiliation:
|
Division of General Surgery, Buddhist Tzu Chi General Hospital, Hualien 970, Taiwan. succ.maeva@msa.hinet.net |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Actins
/
metabolism Apoptosis / drug effects Breast Neoplasms / metabolism*, pathology Caspase 8 / metabolism Cell Line, Tumor Humans Phenanthrenes / pharmacology* bcl-2-Associated X Protein / metabolism* bcl-X Protein / metabolism* |
| Chemical | |
Reg. No./Substance:
|
0/Actins; 0/Phenanthrenes; 0/bcl-2-Associated X Protein; 0/bcl-X Protein; 568-73-0/tanshinone; EC 3.4.22.-/Caspase 8 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Radix clematidis extract protects against cytokine- and streptozotocin-induced beta-cell damage by s...
Next Document: Neuromedin U directly stimulates growth of cultured rat calvarial osteoblast-like cells acting via t...